|Gerresheimer AG -- USA Stock|| |
USD 88.75 0.00 0.00%
Member of the Supervisory Board
Mr. Udo J. Vetter was Member of the Supervisory Board of Gerresheimer AG since May 14, 2007. He is a Pharmacist und General Partner of UVCap GmbH Co. KG, Ravensburg. He is also Chairman of the Supervisory Board at EDT AG, ItM AG, Vetter Pharma Fertigungs GmbH Co. KG, Paschal Werk G. Maier GmbH, Medisynthana GmbH, Atoll GmbH and SeaLionPharman Pte. Ltd. Furthermore, he is Member of the Supervisory Board at HSM GmbH Co. KG, K M Praezisionstechnik GmbH and Gland Pharma Pte. Ltd., among others. He was Managing Director of Vetter Injekt System GmbH Co. KG between 1989 and 2003. He was also Member of the Executive Committee of the Vetter Group between 1999 and 2003. In 2004 he was appointed as Managing Partner of the UVCap GmbH Co. KG private equity company. Since 2006 he has also been Managing Partner of the real estate holding MMC GmbH Co. KG. In 2007 he joined the Advisory Board of Vetter Pharma Fertigung GmbH Co. KG and since 2008 he was Advisory Board Chairman. In 2007 he was appointed to the Vetter Executive Committee. He graduated from University of Washington with BS in Pharmacy. He is Member of the Nomination Committee at the Company.
Age: 62 Executive Since 2007
49 211 61 81 00 http://www.gerresheimer.com
The company has return on total asset (ROA)
of 4.41 %
which means that it generated profit of $4.41 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 12.56 %
meaning that it generated $12.56 on every $100 dollars invested by stockholders.
The company has accumulated 1.13 B in total debt with debt to equity ratio (D/E) of 120.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Gerresheimer AG has Current Ratio of 0.71 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. Gerresheimer AG was founded in 1864 and is headquartered in Dsseldorf, Germany. Gerresheimer AG is traded on OTC Market in USA.Gerresheimer AG (GRRMF) is traded on OTC Market in USA. It is located in Klaus-Bungert-Strasse 4 and employs 9,808 people.